Looking to sell Orbital Therapeutics stock or options?
Orbital Therapeutics is developing an RNA therapeutics platform designed to incorporate a comprehensive array of established and emerging technologies, alongside advanced delivery systems. The company's goal is to advance a wide-ranging and transformative portfolio of RNA-based therapies targeting various human diseases. This includes areas such as vaccines, immunomodulation, protein replacement, and regenerative medicine, offering patients modern treatment options for a variety of conditions.
The Invus Group, Alexandria Venture Investments, Redmile Group, iGlobe Partners, ARCH Venture Partners, Heritage Medical Systems, Rsquared, Agent Capital, Moore Capital Management, Rellim Capital Management, Moore Strategic Ventures, Andreessen Horowitz, Newpath Partners, Casdin Capital, Exor.